Decreased expression of peroxisome proliferator-activated receptor γ in endotoxin-induced acute lung injury

Physiological Research

Volumn 55, Issue 3, 2006, Pages 291-299

  Liu, D ^a   Xiong Zeng, B ^b   Shang, Y ^b  

^a LANZHOU GENERAL HOSPITAL   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Acute lung injury; Endotoxin; Nuclear factor B; Peroxisome proliferator activated receptor

Indexed keywords

ENDOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MYELOPEROXIDASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SODIUM CHLORIDE; SYNAPTOTAGMIN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRY WEIGHT; ENDOTOXEMIA; ENZYME ACTIVITY; ENZYME ASSAY; HISTOPATHOLOGY; INFLAMMATION; LUNG; LUNG PARENCHYMA; LUNG WEIGHT; MALE; NONHUMAN; PLASMA; PNEUMONIA; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REGULATORY MECHANISM; TIME; TISSUE LEVEL;

ANIMALS; BLOTTING, WESTERN; GENE EXPRESSION; LIPOPOLYSACCHARIDES; LUNG; MALE; PEROXIDASE; PPAR GAMMA; PULMONARY EDEMA; RATS; RATS, WISTAR; RESPIRATORY DISTRESS SYNDROME, ADULT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33745188504     PISSN: 08628408     EISSN: 08628408     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. ABRAHAM E: Neutrophils and acute lung injury. Crit Care Med 31: S195-S199, 2003.
2. ADAMS M, REGINATO MJ, SHAO D, LAZAR MA, CHATTERJEE VK: Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen- activated protein kinase site. J Biol Chem 272: 5128-5132, 1997.
3. ALI S, MANN DA: Signal transduction via the NF-κB pathway: a targeted treatment modality for infection, inflammation and repair. Cell Biochem Funct 22: 67-79, 2004.
4. AMESHIMA S, GOLPON H, COOL CD, CHAN D, VANDIVIER RW, GARDAI SJ, WICK M, NEMENOFF RA, GERACI MW, VOELKEL NF: Peroxisome proliferator-activated receptor gamma (PPARγ) expression is decreased in pulmonary hypertension and affects endothelial cell growth. Circ Res 92: 1162-1169, 2003.
5. BALIBREA JL, ARIAS-DÍAZ J: Acute respiratory distress syndrome in the septic surgical patient. World J Surg 27: 1275-1284, 2003.
6. BHATIA M, MOOCHHALA S: Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol 202: 145-156, 2004.
7. BLANQUART C, BARBIER O, FRUCHART JC, STALES B, GLINEUR C: Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation. J Steroid Biochem Mol Biol 85: 267-273, 2003.
8. CONDLIFFE AM, CHILVERS ER, HASLETT C, DRANSFIELD I: Priming differentially regulates neutrophil adhesion molecule expression/function. Immunology 89: 105-111, 1996.
9. CUZZOCREA S, PISANO B, DUGO L, IANARO A, PATEL NS, DI PAOLA R, GENOVESE T, CHATTERJEE PK, FULIA F, CUZZOCREA E, DI ROSA M, CAPUTI AP, THIEMERMANN C: Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-γ, reduces the development of nonseptic shock induced by zymosan in mice. Crit Care Med 32: 457-466, 2004.
10. DROST EM, MACNEE W: Potential role of IL-8, platelet-activating factor and TNF-alpha in the sequestration of neutrophils in the lung: effects on neutrophil deformability, adhesion receptor expression, and chemotaxis. Eur J Immunol 32: 393-403, 2002.
11. FAHMI H, DI BATTISTA JA, PELLETIER JP, MINEAU F, RANGER P, MARTEL-PELLETIER J: Peroxisome proliferator-activated receptor γ activators inhibit interleukin-1β-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes. Arthritis Rheum 44: 595-607, 2001.
12. FEINGOLD K, KIM MS, SHIGENAGA J, MOSER A, GRUNFELD C: Altered expression of nuclear hormone receptors and coactivators in mouse heart during the acute-phase response. Am J Physiol 286: E201-E207, 2004.
13. 2 on bleomycin-induced lung injury. Eur Respir J 25: 225-234, 2005.
14. GHOSH S, LATIMER RD, GRAY BM, HARWOOD RJ, ODURO A: Endotoxin-induced organ injury. Crit Care Med 21: S19-S24, 1993.
15. GRAY KD, SIMOVIC MO, CHAPMAN WC, BLACKWELL TS, CHRISTMAN JW, MAY AK, PARMAN KS, STAIN SC: Endotoxin potentiates lung injury in cerulein-induced pancreatitis. Am J Surg 186: 526-530, 2003.
16. GUYTON K, ZINGARELLI B, ASHTON S, TETI G, TEMPEL G, REILLY C, GILKESON G, HALUSHKA P, COOK J: Peroxisome proliferator-activated receptor-gamma agonists modulate macrophage activation by gram-negative and gram-positive bacterial stimuli. Shock 20: 56-62, 2003.
17. HILL MR, YOUNG MD, McCURDY CM, GIMBLE JM: Decreased expression of murine PPARγ in adipose tissue during endotoxemia. Endocrinology 138: 3073-3076, 1997.
18. JIANG C, TING AT, SEED B: PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391: 82-86, 1998.
19. KABIR K, GELINAS JP, CHEN M, CHEN D, ZHANG D, LUO X, YANG JH, CARTER D, RABINOVICI R: Characterization of a murine model of endotoxin-induced acute lung injury. Shock 17: 300-303, 2002.
20. KATAYAMA K, WADA K, NAKAJIMA A, MIZUGUCHI H, HAYAKAWA T, NAKAGAWA S, KADOWAKI T, NAGAI R, KAMISAKI Y, BLUMBERG RS, MAYUMI T: A novel PPARγ gene therapy to control inflammation associated with inflammatory bowel disease in a murine model. Gastroenterology 124: 1315-1324, 2003.
21. LIM CM, KIM EK, KOH Y, KIM WS, KIM DS, KIM WD: Hypothermia inhibits cytokine release of alveolar macrophage and activation of nuclear factor κB in endotoxemic lung. Intensive Care Med 30: 1638-1644, 2004.
22. LIU D, ZENG BX, ZHANG SH, WANG YL, ZENG L, GENG ZL, ZHANG SF: Rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, reduces acute lung injury in endotoxemic rats. Crit Care Med 32: 2309-2316, 2005.
23. LIU SF, YE X, MALIK AB: Pyrrolidine dithiocarbamate prevents IκB degradation and reduces microvascular injury induced by lipopolysaccharide in multiple organs. Mol Pharmacol 55: 658-667, 1999.
24. MICHAEL LF, LAZAR MA, MENDELSON CR: Peroxisome proliferator-activated receptor γ1 expression is induced during cyclic adenosine monophosphate-stimulated differentiation of alveolar type II pneumonocytes. Endocrinology 138: 3695-3703, 1997.
25. PASCERI V, WU HD, WILLERSON JT, YEH ET: Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators. Circulation 101: 235-238, 2000.
26. PATEL HJ, BELVISI MG, BISHOP-BAILEY D, YACOUB MH, MITCHELL JA: Activation of peroxisome proliferator-activated receptors in human airway smooth muscle cells has a superior anti-inflammatory profile to corticosteroids: relevance for chronic obstructive pulmonary disease therapy. J Immunol 170: 2663-2669, 2003.
27. REDDY RC, KESHAMOUNI VG, JAIGIRDAR SH, ZENG X, LEFF T, THANNICKAL VJ, STANDIFORD TJ: Deactivation of murine alveolar macrophages by peroxisome proliferator-activated receptor-γ ligands. Am J Physiol 286: L613-L619, 2004.
28. SHIBUYA A, WADA K, NAKAJIMA A, SAEKI M, KATAYAMA K, MAYUMI T, KADOWAKI T, NIWA H, KAMISAKI Y: Nitration of PPARγ inhibits ligand-dependent translocation into the nucleus in a macrophage-like cell line RAW 264. FEBS Lett 525: 43- 47, 2002.
29. TAKAO Y, MIKAWA K, NISHINA K, OBARA H: Attenuation of acute lung injury with propofol in endotoxemia. Anesth Analg 100: 810-816, 2005.
30. TANAKA T, ITOH H, DOI K, FUKUNAGA Y, HOSODA K, SHINTANI M, YAMASHITA J, CHUN TH, INOUE M, MASATSUGU K, SAWADA N, SAITO T, INOUE G, NISHIMURA H, YOSHIMASA Y, NAKAO K: Down regulation of peroxisome proliferator-activated receptor-γ expression by inflammatory cytokines and its reversal by thiazolidinediones. Diabetologia 42: 702-710, 1999.
31. TIAN J, LIN X, GUAN R, XU JG: The effects of hydroxyethyl starch on lung capillary permeability in endotoxic rats and possible mechanisms. Anesth Analg 98: 768-774, 2004.
32. WANG AC, DAI X, LUU B, CONRAD DJ: Peroxisome proliferator-activated receptor-γ regulates airway epithelial cell activation. Am J Respir Cell Mol Biol 24: 688-693, 2001.
33. YOSHINARI D, TAKEYOSHI I, KOIBUCHI Y, MATSUMOTO K, KAWASHIMA Y, KOYAMA T, OHWADA S, MORISHITA Y: Effects of a dual inhibitor of tumor necrosis factor-α and interleukin-1 on lipopolysaccharide-induced lung injury in rats: involvement of the p38 mitogen-activated protein kinase pathway. Crit Care Med 29: 628-634, 2001.
34. 2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathyways. J Immunol 171: 6827-6837, 2003.